medline.ch Urologie-Nephrologie

	Lipids in kidney diseases: from systemic imbalance to intrarenal alterations of cellular lipid metabolism in rare and common kidney diseases. J Mol Med (Berl) Garavaglia C, Ossoli A, Gomaraschi M. PMID: 41714434 [PubMed - indexed for MEDLINE]
	De novo HLA antibodies after blood transfusion and/or kidney transplant in children with kidney disease. Pediatr Nephrol McComish JS, Bell L, Kausman J. PMID: 41714422 [PubMed - as supplied by publisher]
	Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy. Pediatr Nephrol Wade J, Thomas DC, Pickering MC, Medjeral-Thomas NR. PMID: 41714421 [PubMed - as supplied by publisher]
	Machine learning based classification of female genital mutilation in 11 Sub-Saharan African countries using demographic and health survey data. Sci Rep Gebrehana AK, Demoze L, Yitageasu G, Kase BF, Tigabie M, Asnake AA. PMID: 41714365 [PubMed - as supplied by publisher]
	Preoperative prediction of preserved renal parenchymal volume via multilevel CT feature fusion: a proof-of-concept study. Abdom Radiol (NY) Wu Z, Liang W, Zeng J, Yin S, Zheng R, Wang D, Zhang C, Wen J, Liu A, Chen C, Liang Y, Liu Q, Chen D, Ye Y. PMID: 41714356 [PubMed - as supplied by publisher]
	The AI Act and the MDR post-market requirements for semiautonomous AI SaMD: a radiology case study in prostate cancer. Abdom Radiol (NY) Shojaei S, Yakar D, Vellinga N, Bozgo V, Kwee T, Huisman H, Mifsud Bonnici JP. PMID: 41714355 [PubMed - as supplied by publisher]
	Review of radiopharmaceutical therapy in prostate cancer. Urol Oncol Miller SR, Dewaraja Y, Rowe SP, Reichert ZR, Viglianti BL. PMID: 41714269 [PubMed - as supplied by publisher]
	Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study. Eur Urol Bancroft EK, Page EC, McHugh J, Thomas S, Taylor N, Pope J, Evans DG, Rothwell J, Grindedal EM, Maehle L, James P, McKinley J, Mascarenhas L, Side L, Thomas T, van Leerdam ME, van Asperen CJ, Kiemeney LALM, Ringelberg J, Vlaming M, Rønlund K, Osther PJS, Helfand BT, Hutten CG, Oldenburg RA, Cybulski C, Wokolorczyk D, Ong KR, Huber C, Salinas M, Feliubadaló L, Oosterwijk JC, van Zelst-Stams WAG, Cook J, Rosario DJ, Maxwell K, Powers J, Buys S, Lyman J, Ausems MGEM, Schmutzler RK, Rhiem K, Izatt L, Tripathi V, Teixeira MR, Cardoso M, Foulkes WD, Aprikian A, Davidson R, Longmuir M, Ruijs MWG, Blom EW, van Engelen K, Williams R, Andrews L, Murphy DG, Saya S, Halliday D, Walker L, Liljegren A, Carlsson S, Azzabi A, Jobson I, Snape K, Gowie M, Harris M, Tischkowitz M, Taylor A, Kirk J, Susman R, Chen-Shtoyerman R, Spigelman A, Pachter N, Ahmed M, Cajal TRY, Krajc M, Cleaver R, Cruellas M, Perez-Ballestero E, Brady AF, Gallagher D, Donaldson A, Barwell J, Nicolai N, Friedman E, Hall MJ, Greenhalgh L, Murthy V, Copakova L, McGrath JS, Cooke P, Arun B, Myhill K, Hogben M, Hussain S, Aaronson NK, Ardern-Jones A, Bangma CH, Castro E, Dearnaley D, Eccles DM, Tricker K, Falconer A, Gronberg H, Hamdy FC, Khoo V, Lilja H, Lindeman GJ, Lubinski J, Axcrona K, Mikropoulos C, Mitra A, Offman J, Rennert G, Suri M, Dudderidge T, IMPACT Study Collaborators, Brook MN, Kote-Jarai Z, Eeles RA. PMID: 41714267 [PubMed - as supplied by publisher]
	Metformin prescription in hospitalized patients with renal impairment: What about in real life? A cross-sectional study. Therapie Tardy L, Beyens MN, Bellet F, Damin-Pernik M. PMID: 41714245 [PubMed - as supplied by publisher]
	Neoadjuvant therapy in gall bladder cancer improves resectability and survival: a prospective study. HPB (Oxford) Lahiri A, Chowdhury S, Goel S, Assif Iqbal S, Aggarwal A, Garg P, Goel V, Talwar V, Sethi J, Singh S. PMID: 41714243 [PubMed - as supplied by publisher]
	Stratifying Risk and Treatment Benefit: A Model Predicting Overall Survival in Men with Metastatic De Novo Hormone-sensitive Prostate Cancer in Trials Investigating Docetaxel (the STOPCAP Collaboration). Eur Urol Focus Halabi S, Luo B, Yu C, Rydzewska LHM, Roy A, Kim H, Godolphin PJ, Murphy L, Carducci MA, Gravis G, Sfumato P, Boher JM, James ND, Tierney JF, Page D, Sweeney C, Guo S. PMID: 41714204 [PubMed - as supplied by publisher]
	Efficacy and Safety of Mirabegron in Patients with Overactive Bladder and Cardiovascular Comorbidities: A Post Hoc Analysis of Randomised Trials. Eur Urol Focus Lockefeer A, Schild A, Anaokar S, Fode M. PMID: 41714203 [PubMed - as supplied by publisher]
	Outcomes and predictors of kidney failure in elderly patients with biopsy-proven IgA nephropathy. Ren Fail , Petre N, Zugravu A, Stancu S. PMID: 41714174 [PubMed - indexed for MEDLINE]
	Differential Response to (177)Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. J Nucl Med Pepin A, Doucette A, Narayan VK, Maxwell KN, Takvorian SU, O'Brien SR, Mankoff DA, Mulugeta PG, Taunk NK. PMID: 41714123 [PubMed - as supplied by publisher]
	Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes. Lupus Sci Med Baker R, Whittall Garcia LP, Li Q, Kim M, Bonilla D, Gladman DD, Urowitz M, Touma Z, Wither J. PMID: 41714112 [PubMed - indexed for MEDLINE]
	A population based, regression discontinuity analysis examined the effects of nationwide alerting for acute kidney injury on healthcare and patient outcomes. Kidney Int Xie M, Geldsetzer P, Blakeman T, James M, Scale T, Tan Z, Sawhney S. PMID: 41713646 [PubMed - as supplied by publisher]
	Green Dialysis: Environmentally Sustainable Care, Growth, and Innovation: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int Barraclough KA, Berman-Parks N, Jha V, Piccoli GB, Stigant C, Talbot B, Tarrass F, Cheung M, King JM, Grams ME, Jadoul M, Flythe JE, Conference Participants. PMID: 41713645 [PubMed - as supplied by publisher]
	cGAS-STING Signaling Pathway in Urogenital Oncology: Regulation, Resistance, and Routes to Response. Crit Rev Oncol Hematol Gong C, Li S, Huang Y, Luo E, Tan Z, Li H, Kong Y, Ding M. PMID: 41713564 [PubMed - as supplied by publisher]
	Outcomes of a Phase II Interventional Clinical Trial of Prostate Bed Stereotactic Body Radiation Therapy for Prostate Cancer with High-Risk Features Following Radical Prostatectomy. Int J Radiat Oncol Biol Phys Vargas CE, Voss MM, Dodoo C, Wong W, Zhu A, Keole SR, Rwigema JC, Davis B, Stish BJ, Laughlin B, Daniels T. PMID: 41713512 [PubMed - as supplied by publisher]
	Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysis. Radiother Oncol Miszczyk M, Sohoni N, Smani S, Moll M, Alfarhan AR, Roessler N, Miyajima K, Inoue S, Marvaso G, Mastroleo F, Zamboglou C, Soeterik TF, Zilli T, Terlizzi M, Blanchard P, Rajwa P, Fazekas T, Ploussard G, An Y, Leapman MS, Blanck O, Jereczek-Fossa BA, Shariat SF. PMID: 41713502 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 466191

Seite 1 von 23310

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung